Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BM8) Ownership - Who Owns BioMarin Pharmaceutical?
0 Followers
BioMarin Pharmaceutical (BM8) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.42% Other Institutional Investors
97.58% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (DE:BM8) stock is a mix of institutional, retail and individual investors. Approximately 2.42% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 97.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2024 | Jean Jacques Bienaime Director | Sold | $172220 |
| Mar 07, 2024 | Henry Fuchs President, Worldwide R&d | Sold | $3010346 |
| Feb 29, 2024 | Jean Jacques Bienaime Director | Sold | $90350 |
| Feb 12, 2024 | Jean Jacques Bienaime Director | Bought | $3704 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $3953 | |
| Dec 31, 2023 | Sold | $235843 | |
| Dec 31, 2023 | Sold | $239410 | |
| Dec 31, 2023 | Bought | $1279107 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 189,020 | Insider | ― | 15,828,535 | |
| 71,467 | Insider | ― | 5,984,647 | |
| 33,140 | Insider | ― | 2,775,144 | |
| 42,840 | Insider | ― | 3,587,422 | |
| 25,590 | Insider | ― | 2,142,907 | |
| 722,527 | Insider | ― | 60,504,411 | |
| 32,750 | Insider | ― | 2,742,485 | |
| 11,875 | Insider | ― | 994,413 | |
| 71,859 | Insider | ― | 6,017,473 | |
| 47,686 | Insider | ― | 3,993,226 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,200 | Institution | ― | 2,349,878 | |
| 397,336 | Institution | ― | 35,637,066 | |
| 335,492 | Institution | ― | 30,090,277 | |
| 47,436 | Institution | ― | 4,254,535 | |
| 2,165 | Institution | ― | 194,179 | |
| 39,624 | Institution | ― | 3,553,877 | |
| 200 | Institution | ― | 17,938 | |
| 32,073 | Institution | ― | 2,876,627 | |
| 425,000 | Institution | ― | 38,118,250 | |
| 11,487 | Institution | ― | 1,030,269 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns BioMarin Pharmaceutical (DE:BM8)?
According to the latest TipRanks data, approximately 2.42% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 97.58% is held by retail investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.42% of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.58% of BioMarin Pharmaceutical (DE:BM8) stock is held by retail investors.
Who owns the most shares of BioMarin Pharmaceutical (DE:BM8)?
Robert Baffi owns the most shares of BioMarin Pharmaceutical (DE:BM8).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.